| D006993 |
Hypnotics and Sedatives |
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. |
Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative |
|
| D008297 |
Male |
|
Males |
|
| D009043 |
Motor Activity |
Body movements of a human or an animal as a behavioral phenomenon. |
Activities, Motor,Activity, Motor,Motor Activities |
|
| D010424 |
Pentobarbital |
A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) |
Mebubarbital,Mebumal,Diabutal,Etaminal,Ethaminal,Nembutal,Pentobarbital Sodium,Pentobarbital, Monosodium Salt,Pentobarbitone,Sagatal,Monosodium Salt Pentobarbital |
|
| D010636 |
Phenols |
Benzene derivatives that include one or more hydroxyl groups attached to the ring structure. |
|
|
| D011412 |
Propanolamines |
AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. |
Aminopropanols |
|
| D002040 |
Levobunolol |
The L-Isomer of bunolol. |
AKBeta,Apo-Levobunolol,Betagan,Levobunolol Hydrochloride,Novo-Levobunolol,PMS-Levobunolol,Ultracortenol,Vistagan,W-7000A,ratio-Levobunolol,Apo Levobunolol,ApoLevobunolol,Novo Levobunolol,NovoLevobunolol,PMS Levobunolol,PMSLevobunolol,W 7000A,W7000A,ratio Levobunolol |
|
| D002490 |
Central Nervous System |
The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. |
Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous |
|
| D003864 |
Depression, Chemical |
The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. |
Chemical Depression,Chemical Depressions,Depressions, Chemical |
|
| D005260 |
Female |
|
Females |
|